NOL3 and breast cancer: ARC abundance increases in multiple human cancers [23–28], and the absence of an effect of nol3 deletion on MEN1 tumor load in this study contrasts with the amelioration of tumor growth (as well as metastasis) resulting from nol3 inactivation in a genetic mouse model of breast cancer [29].